Prospective Study of Clinical Utility of Acupuncture in Back Pain (PUCTURE-CV)

November 7, 2011 updated by: Group G-6

Prospective Epidemiological Study To Evaluate The Clinical Utility Of Acupuncture In The Treatment Of Back Pain (Study PUCTURE-CV)

The purpose of this study is to evaluate prospectively the effectiveness of acupuncture as adjunctive therapy in the treatment of spinal pain is the three backbone areas: cervical, thoracic and lumbar pain, under conditions of usual clinical practice as the medical acupuncturist performed acupuncture, with and without supplementary pharmacological treatment during the first 4 weeks of follow up.

Study Overview

Status

Unknown

Detailed Description

Epidemiological, observational, prospective, with two cohorts, naturalistic and non-interventionist study.

The disease to be studied is Back pain (cervical, thoracic or lumbar) caused by musculoskeletal pathologies and previously treated with conventional medical treatment with or without treatment currently.

Study Type

Observational

Enrollment (Anticipated)

102

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Madrid, Spain, 20010
        • I.H. Hospital San Jose

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study population is patients who go to the Acupuncture Office diagnosed of cervical, thoracic or lumbar pain caused by musculoskeletal diseases, pretreated with pharmacological treatment, they start treatment with acupuncture as adjunctive therapy for symptoms of their disease.

Initially it was estimated that the optimal number of patients included to achieve the objectives of the study is 102 patients

Description

Inclusion Criteria:

  • Patients of both sexes, aged 18 and over
  • Patients diagnosed with back pain: cervical, thoracic or lumbar.
  • Patients who has received appropriate medical treatment for their disease: analgesics, anti-inflammatories, or other treatments, but painful and symptoms persist
  • Patients that could receive acupuncture treatment in order to reduce the symptoms and reviewed by a medical acupuncturist
  • Patients with sufficient cultural and educational level to complete the health questionnaires required in the study
  • Patients who have given their written informed consent to participate in the study

Exclusion Criteria:

  • Patient with any illness and that medical opinions recommended not to participate in the study
  • Patient can not respond to questionnaires administered during the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
With usual concomitant treatment
Two observational cohorts of patients will be evaluated: with and without concomitant analgesic/ antiinflammatory drugs. The objective is evaluate that both therapies (drugs and acupuncture) could be used as adjunctive therapy in order to maximize the analgesia that could be reached
Without usual concomitant treatment
This group include patients that are not been treated with analgesic drugs at the beginning of the study. As an observational and naturalistic study any indicated treatment is allowed in any time

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAS: Visual Analogic Scale of pain
Time Frame: 10 weekly visits
Pain assesment will be evaluated using a Visual Analogic Scale of pain (VAS). This variable will be evaluated in all 10 visits and it will be showed its evolution (decrease) along the study
10 weekly visits

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sheehan Disability Questionnaire
Time Frame: First Visit (week 1) and Final Visit (week 10)
Sheehan Disability Questionnaire, this validated questionnaire will be administrated in Visit 1 (Basal) and Visit 10 (Final) and it will be compared if there has been statistical differences between both evaluations
First Visit (week 1) and Final Visit (week 10)
Evaluation of the Scale Hospital Anxiety Depression (HAD)
Time Frame: First Visit (week 1) and Final Visit (week 10)
Scale Hospital Anxiety Depression (HAD), this scale will be evaluated using a validated questionnaire administrated in Visit 1 (basal) and Visit 10 (Final) and it will be compared if there has been statistical differences between both evaluations
First Visit (week 1) and Final Visit (week 10)
Health Questionnaire EuroQol-5D
Time Frame: First Visit (week 1) and Final Visit (week 10)
Health Questionnaire EuroQol-5D, this validated questionnaire will be administrated in Visit 1 (Basal) and Visit 10 (Final) and it will be compared if there has been statistical differences between both evaluations
First Visit (week 1) and Final Visit (week 10)
Assessment of sleep with the integrated scale MOS (Medical Outcomes Study)
Time Frame: First Visit (week 1) and Final Visit (week 10)
Assessment of sleep with the integrated scale MOS (Medical Outcomes Study), this scale will be evaluated using a validated questionnaire administrated in Visit 1 (basal) and Visit 10 (Final) and it will be compared if there has been statistical differences between both evaluations
First Visit (week 1) and Final Visit (week 10)
McGill Pain Questionnaire
Time Frame: 10 weekly visits
A secondary evaluation of pain suffered by the patients will be evaluated using the validated McGill Pain Questionnaire. This questionnaire will be adminstrated in all 10 visits and it will be showed its evolution (decrease) along the study
10 weekly visits

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Valentin Martin, MD, PhD, Grupo G6

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2010

Primary Completion (Anticipated)

June 1, 2012

Study Completion (Anticipated)

October 1, 2012

Study Registration Dates

First Submitted

September 28, 2010

First Submitted That Met QC Criteria

October 28, 2010

First Posted (Estimate)

November 1, 2010

Study Record Updates

Last Update Posted (Estimate)

November 8, 2011

Last Update Submitted That Met QC Criteria

November 7, 2011

Last Verified

November 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • GE6-ACU-2010-01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Back Pain

Subscribe